ArticleCancers2022

The Microtubule Destabilizer Eribulin Synergizes with STING Agonists to Promote Antitumor Efficacy in Triple-Negative Breast Cancer Models.

Leila Takahashi-Ruiz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.